BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus

NCT02183324 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Low dose of BI 1356 BS
DRUG: Medium dose of BI 1356 BS
DRUG: High dose of BI 1356 BS
DRUG: Placebo

Sponsor

Boehringer Ingelheim